2.71
price down icon3.56%   -0.10
pre-market  プレマーケット:  2.76   0.05   +1.85%
loading
前日終値:
$2.81
開ける:
$2.97
24時間の取引高:
621.15K
Relative Volume:
2.17
時価総額:
$75.00M
収益:
-
当期純損益:
$-94.11M
株価収益率:
-0.4509
EPS:
-6.01
ネットキャッシュフロー:
$-86.06M
1週間 パフォーマンス:
-24.51%
1か月 パフォーマンス:
-20.99%
6か月 パフォーマンス:
-65.65%
1年 パフォーマンス:
-70.86%
1日の値動き範囲:
Value
$2.66
$3.005
1週間の範囲:
Value
$2.66
$3.575
52週間の値動き範囲:
Value
$2.64
$10.14

Adverum Biotechnologies Inc Stock (ADVM) Company Profile

Name
名前
Adverum Biotechnologies Inc
Name
セクター
Healthcare (1154)
Name
電話
(650) 649-1004
Name
住所
100 CARDINAL WAY, REDWOOD CITY, CA
Name
職員
155
Name
Twitter
@adverumbio
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
ADVM's Discussions on Twitter

ADVM を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ADVM
Adverum Biotechnologies Inc
2.71 75.00M 0 -94.11M -86.06M -6.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
439.37 128.45B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.63 65.17B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
560.90 40.09B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.19 35.67B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
233.25 27.44B 3.81B -644.79M -669.77M -6.24

Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-06-25 開始されました Oppenheimer Outperform
2024-04-30 開始されました H.C. Wainwright Buy
2022-07-07 アップグレード Truist Hold → Buy
2021-07-23 ダウングレード Cantor Fitzgerald Overweight → Neutral
2021-05-03 ダウングレード SVB Leerink Outperform → Mkt Perform
2021-04-29 ダウングレード Chardan Capital Markets Buy → Neutral
2021-04-29 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2021-04-29 ダウングレード Truist Buy → Hold
2020-12-16 開始されました UBS Neutral
2020-11-12 アップグレード Raymond James Underperform → Mkt Perform
2020-06-26 ダウングレード Raymond James Mkt Perform → Underperform
2020-05-13 開始されました RBC Capital Mkts Outperform
2020-05-05 アップグレード SunTrust Hold → Buy
2020-04-28 開始されました Goldman Buy
2020-03-16 開始されました SVB Leerink Outperform
2020-02-10 アップグレード Cantor Fitzgerald Neutral → Overweight
2020-02-10 アップグレード Chardan Capital Markets Neutral → Buy
2019-10-15 繰り返されました Chardan Capital Markets Neutral
2019-09-13 繰り返されました Chardan Capital Markets Neutral
2019-06-14 再開されました Raymond James Mkt Perform
2018-11-02 ダウングレード Raymond James Outperform → Mkt Perform
2018-11-02 ダウングレード SunTrust Buy → Hold
2018-09-21 開始されました Cantor Fitzgerald Overweight
2018-08-30 開始されました SunTrust Buy
2018-02-15 再開されました Piper Jaffray Overweight
2017-10-12 開始されました Raymond James Outperform
すべてを表示

Adverum Biotechnologies Inc (ADVM) 最新ニュース

pulisher
May 07, 2025

Adverum Biotechnologies Inc (ADVM)’s Market Momentum: Closing Strong at 3.23, Down -10.03 - DWinneX

May 07, 2025
pulisher
May 07, 2025

Adverum Biotechnologies’ SWOT analysis: gene therapy firm faces pivotal year - Investing.com Nigeria

May 07, 2025
pulisher
May 06, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc.ADVM - PR Newswire

May 06, 2025
pulisher
May 06, 2025

Adverum Biotechnologies' SWOT analysis: gene therapy firm faces pivotal year - Investing.com

May 06, 2025
pulisher
May 05, 2025

Adverum Biotechnologies Inc expected to post a loss of $1.94 a shareEarnings Preview - TradingView

May 05, 2025
pulisher
May 02, 2025

Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

May 02, 2025
pulisher
May 02, 2025

Adverum Biotechnologies Awards Strategic Stock Options Worth $108,000 to Expand Team - Stock Titan

May 02, 2025
pulisher
May 02, 2025

It makes sense and dollars to buy Adverum Biotechnologies Inc (ADVM) stock - Sete News

May 02, 2025
pulisher
Apr 30, 2025

Adverum Biotechnologies Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - investchronicle.com

Apr 30, 2025
pulisher
Apr 28, 2025

Adverum Biotechnologies Inc [ADVM] Investment Guide: What You Need to Know - knoxdaily.com

Apr 28, 2025
pulisher
Apr 28, 2025

Should investors be concerned about Adverum Biotechnologies Inc (ADVM)? - uspostnews.com

Apr 28, 2025
pulisher
Apr 28, 2025

Gaining Ground: Adverum Biotechnologies Inc (ADVM) Closes Lower at 2.91, Down -2.02 - DWinneX

Apr 28, 2025
pulisher
Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 24, 2025

Hedge Fund and Insider Trading News: Ken Griffin, Steve Cohen, Scott Bessent, Balyasny Asset Management, Bridgewater Associates, Starboard Value, Maverick Capital, Kodai Capital Management, Antara Capital, Adverum Biotechnologies Inc (ADVM), and - Insider Monkey

Apr 24, 2025
pulisher
Apr 24, 2025

Adverum Biotechnologies Insider Bought Shares Worth $1,048,950, According to a Recent SEC Filing - marketscreener.com

Apr 24, 2025
pulisher
Apr 24, 2025

Adverum Biotechnologies Insider Buys 350,000 Shares - TradingView

Apr 24, 2025
pulisher
Apr 23, 2025

Adverum Biotechnologies Inc (ADVM) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com

Apr 23, 2025
pulisher
Apr 23, 2025

Trading Day Triumph: Adverum Biotechnologies Inc (ADVM) Ends at 2.96, a 8.42 Surge/Plunge - DWinneX

Apr 23, 2025
pulisher
Apr 21, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Adverum Biotechnologies, Inc. (ADVM) Stockholders to Inquire about Securities Investigation - markets.businessinsider.com

Apr 21, 2025
pulisher
Apr 21, 2025

Truist Removes $40 Price Target on Adverum Biotechnologies, Cites Share Volatility, Keeps Buy Rating - marketscreener.com

Apr 21, 2025
pulisher
Apr 20, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Adverum Biotechnologies, Inc. (ADVM) Investors to Inquire about Securities Investigation - markets.businessinsider.com

Apr 20, 2025
pulisher
Apr 20, 2025

Chardan Capital Cuts Adverum Biotechnologies (NASDAQ:ADVM) Price Target to $33.00 - American Banking and Market News

Apr 20, 2025
pulisher
Apr 18, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Adverum Biotechnologies, Inc. (ADVM) And Encourages Investors to Reach Out - markets.businessinsider.com

Apr 18, 2025
pulisher
Apr 18, 2025

Adverum Biotechnologies (NASDAQ:ADVM) Earns Buy Rating from HC Wainwright - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Adverum Biotechnologies, Inc. (ADVM) And Encourages Stockholders to Reach Out - markets.businessinsider.com

Apr 17, 2025
pulisher
Apr 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Adverum Biotechnologies, Inc. - GlobeNewswire Inc.

Apr 17, 2025
pulisher
Apr 17, 2025

Intuit To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga

Apr 17, 2025
pulisher
Apr 16, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Adverum Biotechnologies, Inc. (ADVM) And Encourages Stockholders to Connect - markets.businessinsider.com

Apr 16, 2025
pulisher
Apr 16, 2025

RBC Cuts Price Target on Adverum Biotechnologies to $5 From $10, Keeps Sector Perform, Speculative Risk - marketscreener.com

Apr 16, 2025
pulisher
Apr 15, 2025

Adverum Biotechnologies Reports 2024 Financial Results and Pipeline Progress - TipRanks

Apr 15, 2025
pulisher
Apr 15, 2025

Adverum Biotechnologies: Q4 Earnings Snapshot - CT Insider

Apr 15, 2025
pulisher
Apr 15, 2025

Adverum Biotechnologies, Inc. (ADVM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com

Apr 15, 2025
pulisher
Apr 15, 2025

ADVM Investors Have Opportunity to Join Adverum Biotechnologies, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire

Apr 15, 2025
pulisher
Apr 15, 2025

Adverum Biotechnologies Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Apr 15, 2025
pulisher
Apr 15, 2025

Adverum Biotechnologies Reports Fourth Quarter and Full - GlobeNewswire

Apr 15, 2025
pulisher
Apr 15, 2025

Adverum Advances Gene Therapy Pipeline Despite Wider Losses: Key Q4 Developments Revealed - Stock Titan

Apr 15, 2025
pulisher
Apr 15, 2025

Adverum Biotechnologies, Inc. SEC 10-K Report - TradingView

Apr 15, 2025
pulisher
Apr 12, 2025

Avalanche Biotechnologies Announces Executive Changes - MarketScreener

Apr 12, 2025
pulisher
Apr 09, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Apr 09, 2025
pulisher
Apr 04, 2025

Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 04, 2025
pulisher
Apr 04, 2025

Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Apr 04, 2025
pulisher
Apr 04, 2025

Adverum Biotech Grants 30,000 Share Options to New Executive: Key Details - Stock Titan

Apr 04, 2025

Adverum Biotechnologies Inc (ADVM) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$67.75
price up icon 4.10%
$19.93
price up icon 2.94%
$33.35
price up icon 0.60%
$25.26
price up icon 5.43%
$97.27
price up icon 4.85%
biotechnology ONC
$233.25
price up icon 0.54%
大文字化:     |  ボリューム (24 時間):